ADVANCING bREAST CANCER RESEARCH
Our Researchers
Providing financial support for breast cancer research has always been a driving force in CURE’s mission. Through strategic partnerships with Canada’s top institutions, the foundation invests in basic, translational and clinical research, all with the goal of improving treatment and finding a cure.
Our Researchers
Dr. Mark Basik
Attending Surgical Oncologist at the Jewish General Hospital, as well as Assistant Professor at the Department of Oncology of McGill University, studies drug resistant breast cancer cells.
Dr. Mark Clemons
Clinical Investigator at the Ottawa Hospital Research Institute (Cancer Therapeutics Program), staff medical oncologist (Ottawa Hospital Cancer Centre) and Professor of Medicine (University of Ottawa)
Dr. Morag Park
Director of McGill University’s Goodman Cancer Research Centre, as well as the Diane and Sal Guerrera Chair in Cancer Genetics, funded through the CURE Foundation.
Dr. Kathryn Isaac
Dr. Patricia Clugston VGH & UBC Hospital Foundation Chair in Breast Reconstruction Surgery
CURE's 2026 Fellowship Spotlight:
Advancing New Treatment Options for Triple-Negative Breast Cancer
As a recipient of the CURE Foundation Fellowship in Breast Cancer Research, Jason is studying triple negative breast cancer (TNBC), one of the most aggressive forms of the disease. While chemotherapy is a primary treatment, some cancer cells survive and can lead to recurrence.
Jason Topolski
MSc Student | Lab of Dr. Morag Park
Department of Biochemistry, McGill University
Rosalind and Morris Goodman Cancer Institute
